jRCT1030230612已完成不适用
Evaluation of satisfaction with orally disintegrating tablets in non-elderly people with type 2 diabetes based on a web survey linked to receipt data
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 400
- 主要终点
- Percentage of people satisfied with orally disintegrating tablets
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20age old over 至 65age old not（—）
- 性别
- All
入选标准
- •People who registered in Pep Up, a PHR service for health insurance societies, provided by JMDC
- •People who have consented to participate in this research
- •Of these, the primary and secondary outcome analysis populations are people who have used orally disintegrating tablets and are confirmed to be people with type 2 diabetes. The target sample size of these people is 400.
排除标准
- •People who belong to the health insurance society of Mitsubishi Tanabe Pharma
- •People who belong to the health insurance society that do not participate in this research
结局指标
主要结局
Percentage of people satisfied with orally disintegrating tablets
Percentage of non-elderly people with type 2 diabetes satisfied with orally disintegrating tablets
次要结局
未报告次要终点
研究者
相似试验
未知
Unknown
Blopress Tablets specified drug-use survey Hypertension: Survey on patients with metabolic syndromeHypertensionJPRN-jRCT1080222516TAKEDA PHARMACEUTICAL COMPANY LTD.15,000
已完成
1 期
The Relative Oral Bioavailability of a Tablet Formulation vs a Solutionof PLN-74809 in Healthy ParticipantsPrimary Sclerosing CholangitisIdiopathic pulmonary fibrosisACTRN12620000573954Pliant Therapeutics, Inc.24
已完成
不适用
THALED CAPSULES Specified Drug Use-results Survey (Crow-Fukase (POEMS) syndrome: Long-term Use)Crow-Fukase (POEMS) syndromeJPRN-UMIN000043600Fujimoto Pharmaceutical Corporation100
已完成
不适用
Palatability of an Oral Dispersible Tablet (ODT) Formulation in ChildrenHealthyNCT03581799University Hospital, Basel, Switzerland40
已完成
不适用
Intuniv Tablets Specified Drug Use Results Survey (Adult)Attention deficit/hyperactivity disorderJPRN-UMIN000040429Takeda Pharmaceutical Co., Ltd.961